Focus Universal Inc (FCUV) News

Exact Sciences schedules second quarter 2024 earnings call

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Form 8-K - Current report

Exact Sciences to Participate in June Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...

ASCO®: Exact Sciences bekräftigt mit mehreren Datenpräsentationen seine langfristige Vorreiterrolle in der Krebsfrüherkennung und bei der Verbesserung von Behandlungsergebnissen

Die vorgestellten Daten ergänzen die Evidenz zum prädiktiven und prognostischen Wert des Oncotype DX® Tests für alle ethnischen...

Exact Sciences démontre son leadership continu en matière de diagnostic précoce du cancer et d’amélioration des résultats pour les patients grâce à de multiples présentations de données à l’ASCO®

Les données qui seront présentées élargissent le corpus de preuves sur la valeur prédictive et pronostique du test Oncotype DX® dans tous les...